Royalty Pharma Investments 2019 ICAV

Track record of Royalty Pharma Investments 2019 ICAV

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Royalty Pharma Investments 2019 ICAV

Co-insiders of Royalty Pharma Investments 2019 ICAV

• Agarwal ShefaliEpizyme, Inc.
• Allen Andrew REpizyme, Inc.
• AMGEN INCEpizyme, Inc.
• Amgen Ventures LLCEpizyme, Inc.
• Astellas Venture Fund I L.P.Epizyme, Inc.
• Astellas Venture Management LLCEpizyme, Inc.
• BARRETT M JAMESEpizyme, Inc.
• BARRIS PETER JEpizyme, Inc.
• BASKETT FORESTEpizyme, Inc.
• BATE KENNETHEpizyme, Inc.
• Bay City Capital Fund V Co-Investment Fund LPEpizyme, Inc.
• Bay City Capital Fund V, L.P.Epizyme, Inc.
• BAY CITY CAPITAL LLCEpizyme, Inc.
• Bay City Capital Management V LLCEpizyme, Inc.
• Bazemore Robert BEpizyme, Inc.
• Beaulieu JosephEpizyme, Inc.
• BEVERIDGE, ROY AEpizyme, Inc.
• Bogle Grant C.Epizyme, Inc.
• CELGENE CORP /DE/Epizyme, Inc.
• Celgene European Investment Co LLCEpizyme, Inc.
• Conroy Kevin TEpizyme, Inc.
• Copeland Robert AEpizyme, Inc.
• Daniel Thomas OEpizyme, Inc.
• DRANT RYAN DEpizyme, Inc.
• EVNIN LUKEEpizyme, Inc.
• Fleming SuzanneEpizyme, Inc.
• Foley ToddEpizyme, Inc.
• GADICKE ANSBERTEpizyme, Inc.
• Garbacz StephenEpizyme, Inc.
• Giordano Michael FEpizyme, Inc.
• GOLDFISCHER CARLEpizyme, Inc.
• Gould Robert JEpizyme, Inc.
• Graf Susan EEpizyme, Inc.
• Hedrick EricEpizyme, Inc.
• Ho Peter Tai-ChingEpizyme, Inc.